Autoimmune Cardiovascular Panel™

About Moleculera Biosciences

Moleculera Biosciences is a commercial-stage precision medicine diagnostics company founded in 2012 and headquartered in Oklahoma City. The company's core offering is the Autoimmune Brain Panel™, a series of blood tests that helps clinicians diagnose immune-mediated neuropsychiatric disorders. Moleculera is leveraging its integrated technology platform—comprising diagnostic panels, a curated biorepository, and a biomarker discovery program—to expand into cardiovascular and Alzheimer's disease markets, addressing significant unmet needs in chronic, treatment-resistant conditions.

Therapeutic Areas